DK1326617T3 - Anvendelse af 11beta- (acetylphenyl) -17beta-hydroxy-17alfa- (1,1,2,2-pentafluorethyl) estra-4,9-dien-3-on til fremstilling af et medikament til behandling af brystcancer, ovariecancer, endometrisk caner, myeloma og meningeom - Google Patents
Anvendelse af 11beta- (acetylphenyl) -17beta-hydroxy-17alfa- (1,1,2,2-pentafluorethyl) estra-4,9-dien-3-on til fremstilling af et medikament til behandling af brystcancer, ovariecancer, endometrisk caner, myeloma og meningeomInfo
- Publication number
- DK1326617T3 DK1326617T3 DK01987669T DK01987669T DK1326617T3 DK 1326617 T3 DK1326617 T3 DK 1326617T3 DK 01987669 T DK01987669 T DK 01987669T DK 01987669 T DK01987669 T DK 01987669T DK 1326617 T3 DK1326617 T3 DK 1326617T3
- Authority
- DK
- Denmark
- Prior art keywords
- cancer
- estra
- acetylphenyl
- dien
- hydroxy
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Steroid Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US24099100P | 2000-10-18 | 2000-10-18 | |
| EP00250342 | 2000-10-18 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1326617T3 true DK1326617T3 (da) | 2006-12-18 |
Family
ID=26072952
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK01987669T DK1326617T3 (da) | 2000-10-18 | 2001-10-17 | Anvendelse af 11beta- (acetylphenyl) -17beta-hydroxy-17alfa- (1,1,2,2-pentafluorethyl) estra-4,9-dien-3-on til fremstilling af et medikament til behandling af brystcancer, ovariecancer, endometrisk caner, myeloma og meningeom |
Country Status (29)
| Country | Link |
|---|---|
| EP (1) | EP1326617B9 (uk) |
| JP (1) | JP2004511523A (uk) |
| KR (1) | KR100668024B1 (uk) |
| CN (1) | CN1209111C (uk) |
| AT (1) | ATE334683T1 (uk) |
| AU (2) | AU2361902A (uk) |
| BG (1) | BG107744A (uk) |
| BR (1) | BR0114696A (uk) |
| CA (1) | CA2423020C (uk) |
| CY (1) | CY1105745T1 (uk) |
| CZ (1) | CZ299823B6 (uk) |
| DE (1) | DE60121980T2 (uk) |
| DK (1) | DK1326617T3 (uk) |
| EA (1) | EA010593B1 (uk) |
| EE (1) | EE200300157A (uk) |
| ES (1) | ES2269492T3 (uk) |
| HK (1) | HK1062273A1 (uk) |
| HR (1) | HRP20030388A2 (uk) |
| HU (1) | HUP0301433A3 (uk) |
| IL (2) | IL154976A0 (uk) |
| MX (1) | MXPA03002955A (uk) |
| NO (1) | NO20031741L (uk) |
| NZ (1) | NZ538347A (uk) |
| PL (1) | PL360157A1 (uk) |
| PT (1) | PT1326617E (uk) |
| SI (1) | SI1326617T1 (uk) |
| SK (1) | SK4702003A3 (uk) |
| UA (1) | UA76729C2 (uk) |
| WO (1) | WO2002032432A1 (uk) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| UY27301A1 (es) * | 2001-05-25 | 2003-02-28 | Schering Ag | Uso y composiciones de antiprogestinas para el tratamiento de enfermedades de la próstata |
| US20040242551A1 (en) * | 2003-05-28 | 2004-12-02 | Schering Ag | Composition comprising antiprogestins and pure antiestrogens for prophylaxis and treatment of hormone-dependent diseases |
| WO2008128791A2 (en) * | 2007-04-23 | 2008-10-30 | Bayer Schering Pharma Aktiengesellschaft | Progesterone-receptor antagonist for use in brca-mediated cancer alone or as combination with antiestrogen |
| US20080268041A1 (en) * | 2007-04-23 | 2008-10-30 | Jens Hoffmann | Combination of progesterone-receptor antagonist together with none-steroidal antiestrogen for use in brca mediated diseases |
| JP2010524996A (ja) * | 2007-04-23 | 2010-07-22 | バイエル・シエーリング・ファーマ アクチエンゲゼルシャフト | Ｂｒｃａ媒介性疾患における使用のための、プロゲステロン受容体拮抗薬と、ルテインホルモン放出ホルモン作動薬および拮抗薬との組み合わせ |
| GB0718167D0 (en) | 2007-09-18 | 2007-10-31 | Cancer Rec Tech Ltd | Cancer marker and therapeutic target |
| CN103957920B (zh) * | 2011-10-04 | 2018-04-20 | 因维维斯制药公司 | 用于鉴定和治疗抗黄体制剂敏感性肿瘤的方法和系统 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19706061A1 (de) * | 1997-02-07 | 1998-08-13 | Schering Ag | Antigestagen wirksame Steroide mit fluorierter 17alpha-Alkylkette |
-
2001
- 2001-10-17 PT PT01987669T patent/PT1326617E/pt unknown
- 2001-10-17 SK SK470-2003A patent/SK4702003A3/sk not_active Application Discontinuation
- 2001-10-17 CA CA002423020A patent/CA2423020C/en not_active Expired - Fee Related
- 2001-10-17 AU AU2361902A patent/AU2361902A/xx active Pending
- 2001-10-17 SI SI200130648T patent/SI1326617T1/sl unknown
- 2001-10-17 AU AU2002223619A patent/AU2002223619B2/en not_active Ceased
- 2001-10-17 PL PL01360157A patent/PL360157A1/xx not_active Application Discontinuation
- 2001-10-17 HU HU0301433A patent/HUP0301433A3/hu unknown
- 2001-10-17 EA EA200300479A patent/EA010593B1/ru not_active IP Right Cessation
- 2001-10-17 EP EP01987669A patent/EP1326617B9/en not_active Expired - Lifetime
- 2001-10-17 KR KR1020037005360A patent/KR100668024B1/ko not_active IP Right Cessation
- 2001-10-17 WO PCT/EP2001/012006 patent/WO2002032432A1/en active IP Right Grant
- 2001-10-17 DK DK01987669T patent/DK1326617T3/da active
- 2001-10-17 CN CNB018175694A patent/CN1209111C/zh not_active Expired - Fee Related
- 2001-10-17 DE DE60121980T patent/DE60121980T2/de not_active Expired - Fee Related
- 2001-10-17 BR BR0114696-3A patent/BR0114696A/pt not_active Application Discontinuation
- 2001-10-17 CZ CZ20031073A patent/CZ299823B6/cs not_active IP Right Cessation
- 2001-10-17 MX MXPA03002955A patent/MXPA03002955A/es active IP Right Grant
- 2001-10-17 JP JP2002535670A patent/JP2004511523A/ja active Pending
- 2001-10-17 ES ES01987669T patent/ES2269492T3/es not_active Expired - Lifetime
- 2001-10-17 EE EEP200300157A patent/EE200300157A/xx unknown
- 2001-10-17 NZ NZ538347A patent/NZ538347A/en unknown
- 2001-10-17 UA UA2003054311A patent/UA76729C2/uk unknown
- 2001-10-17 IL IL15497601A patent/IL154976A0/xx active IP Right Grant
- 2001-10-17 AT AT01987669T patent/ATE334683T1/de not_active IP Right Cessation
-
2003
- 2003-03-18 IL IL154976A patent/IL154976A/en not_active IP Right Cessation
- 2003-04-15 NO NO20031741A patent/NO20031741L/no not_active Application Discontinuation
- 2003-04-18 BG BG107744A patent/BG107744A/bg unknown
- 2003-05-14 HR HR20030388A patent/HRP20030388A2/hr not_active Application Discontinuation
-
2004
- 2004-07-20 HK HK04105309A patent/HK1062273A1/xx not_active IP Right Cessation
-
2006
- 2006-11-01 CY CY20061101564T patent/CY1105745T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1104981T1 (el) | Χρηση των αντιπρογεστερονων για προληψη και αντιμετωπιση των εξαρτωμενων απο ορμονες ασθενειων | |
| DK1326617T3 (da) | Anvendelse af 11beta- (acetylphenyl) -17beta-hydroxy-17alfa- (1,1,2,2-pentafluorethyl) estra-4,9-dien-3-on til fremstilling af et medikament til behandling af brystcancer, ovariecancer, endometrisk caner, myeloma og meningeom | |
| DK1525215T3 (da) | Modulatorer for receptoren for progesteron med forhöjet anti-gonadotrop aktivitet til fertilitetskontrol hos kvinder og ved terapi til erstatning af hormoner | |
| YU29903A (sh) | Upotreba antiprogestina za indukciju apoptoze u ćeliji | |
| JP2004511523A5 (uk) | ||
| MXPA05012841A (es) | Composicion que comprende antagonistas de receptores de progesterona y antiestrogenos puros para la profilaxis y el tratamiento de enfermedades dependientes de hormonas. | |
| IS2702B (is) | Notkun á (11beta, 17beta)-11-(1,3-bensódíoxól-5-ýl)-17-hýdroxý-17-(1-própýnýl)-estra-4,9-díen-3-ón í meðhöndluninni á alvarlegri geðdeyfðartruflun | |
| YU30103A (sh) | Upotreba antiprogestina za profilaksu i lečenje hormonski zavisnih bolesti | |
| DE60022517D1 (de) | Zusammensetzung mit steoridisher östrogen wirkung ohne steigerung des brustkrebsrisikos | |
| TW200733955A (en) | Use of antiprogestins for prophylaxis and treatment of hormone-dependent diseases |